SYNERGY™

Everolimus-Eluting Platinum Chromium Coronary Stent System

A Meaningful Step Forward in Stent Technology

The SYNERGY BP Stent is the first and only FDA-approved drug-eluting stent with abluminal bioabsorbable polymer coating available in the U.S. It was designed to address the challenges associated with permanent polymer stents such as inflammation, neoatherosclerosis and late stent thrombosis.

The SYNERGY BP Stent provides synchronous drug elution and polymer absorption; the polymer is absorbed shortly after the drug elution is complete at 3-months, providing rapid healing and freedom from long-term polymer exposure. Learn more

Watch Video: EVOLVE II 3-Year Clinical Trial Results

Dr. Dean Kereiakes and Prof. Ian Meredith discuss the 3-year results from the EVOLVE II Trial and the body of evidence supporting the SYNERGY BP Stent.
EVOLVE II 3-Year Clinical Trial Results
 
Early Healing

Early Healing

Advanced design for optimal healing

Button
Clinical Outcomes

Clinical Outcomes

Outstanding evidence across trials

Button
Efficiency

Efficiency

How design impacts economic value

Button
Top